Printer Friendly

CDT Systems Receives Second License for Manufacturing Carbon Aerogel.

SciTech21-21 September 2006-CDT Systems Receives Second License for Manufacturing Carbon Aerogel(C)2006 JeraOne - http://www.jeraone.com

The Regents of the University of California, under its U.S. Department of Energy contract to manage and operate Lawrence Livermore National Laboratory, and CDT Systems Inc. have executed an additional license that will allow CDT Systems to manufacture and market the patented Carbon Aerogel worldwide, except for capacitor fields of use.

CDT is the nonexclusive business, technology licensee, and manufacturing associate of the U.S. Department of Energy's Lawrence Livermore National Laboratory (LLNL) for the development and commercialization of Carbon Aerogel material sciences-based capacitive deionization technology (CDT) for water purification, as well as Carbon Aerogel for hydrogen generation, insulation, including fuel cells and nanotechnology electrodes.

This second LLNL license specifically authorizes CDT Systems to manufacture Carbon Aerogel for use as an electrode for the generation of hydrogen from water by hydrolysis and the development of proprietary variable pore-size Carbon Aerogel electrodes.

CDT Systems' manufacturing facility is scheduled to initially produce 80,000-square-feet of proprietary Carbon Aerogel electrodes per month. Current Carbon Aerogel applications include brackish water desalination, industrial and coalbed methane groundwater water remediation, hydrogen generation and Carbon Aerogel for CDT Systems' alliance partners' technologies.

CDT Systems currently has a patent license agreement with LLNL for Capacitive Deionization Technology for brackish water/sea water desalination and treatment of heat exchanger and boiler water, industrial and commercial process water and ultrapure industrial water.

((Comments on this story may be sent to newsdesk@jeraone.com))

((Distributed via M2 Communications Ltd - http://www.m2.com))
COPYRIGHT 2006 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:SciTech21
Date:Sep 21, 2006
Words:261
Previous Article:Progenics Pharmaceuticals Inc. and Wyeth Pharmaceuticals Begin Phase 3 Trials on Treatment of Post-Operative Ileus.
Next Article:Nokia Leads Group of Manufacturers Pledging to Improve 'Environmental Performance' of Mobile Phones.


Related Articles
CDT Systems Receives Second License for Manufacturing Carbon Aerogel for Fuel Cells, Nanotechnology Electrodes.

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |